The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

16 Nov 2009 13:19

RNS Number : 5697C
British SmallerTechCompaniesVCT2PLC
16 November 2009
 



BRITISH SMALLER TECHNOLOGY COMPANIES VCT 2 PLC ("the Company")

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2009

British Smaller Technology Companies VCT 2 plc presents its interim management statement for the quarter ended 30 September 2009. This constitutes the Company's second interim management statement for the financial year ending 31 December 2009, as required by Rule 4.3 of the Disclosure and Transparency Rules. A copy of this interim management statement can be found at www.yfmgroup.co.uk.

The unaudited net asset value per Ordinary share as at 30 September 2009 was 73.0p (30 June 200975.7p). The net asset value as at 30 September 2009 is stated after taking account of the interim dividend of 2.0p per Ordinary share and the special dividend of 2.0p per Ordinary share in respect of the year ended 31 December 2009. These dividends were paid on 2 October 2009 and 30 October 2009 respectively.

The total return at 30 September 2009, calculated by reference to the net asset value per share and the cumulative dividends paid and proposed, increased to 95.0p per share from 93.7p at 30 June 2009.

The number of Ordinary shares in issue at 30 September 2009 was 16,641,257. There were no shares purchased or issued by the Company during the quarter.

Net assets at 30 September 2009 comprised the following:

£000

% of net assets

Unquoted investments at fair value

4,677

38.5%

Quoted investments at bid price

1,023

8.4%

Gilt investments

3,898

32.1%

Total investments

9,598

79.0%

Cash and cash equivalents

1,986

16.3%

Other net current assets (liabilities)

570

4.7%

Net assets

12,154

100.0%

The ten largest investments by valuation at 30 September 2009 were as follows:

£000

% of net assets

Digital Healthcare Limited

1,659

13.6%

Immunobiology Limited

807

6.6%

Primal Pictures Limited

742

6.1%

Pressure Technologies plc

440

3.6%

Silistix Limited

387

3.2%

Waterfall Services Limited

382

3.2%

Harvey Jones Limited

273

2.3%

Patsystems plc

258

2.1%

Ellfin Home Care Limited

150

1.2%

RMS Group Holdings Limited

146

1.2%

Top ten investments

5,244

43.1%

Other investments

456

3.8%

Gilt investments

3,898

32.1%

Total investments

9,598

79.0%

Quoted investments are carried at bid price at 30 September 2009. Unquoted investment are carried at fair value as at 30 September 2009 as determined by the directors.

During the three months ended 30 September 2009 the following significant investment transactions took place (all companies are unquoted except where otherwise indicated):

Disposals

Name of company:

Sale proceeds

£000

Original 

cost

£000

Carrying value at 

30 June 2009

£000

DxS 

1,755*

163

817

ART Technology Group (AiM)

567

244

519

Oxonica (AiM)

3

62

6

RMS Group Holdings 

3

3

3

2,328

472

1,345

* excluding deferred proceeds of £214,000

Performance 

In this period the Company has seen its underlying net asset value decrease by 2.7p per share after the payment of an interim dividend of 2.0p per Ordinary share and a special dividend of 2.0p per Ordinary share. 

The total return, calculated by reference to the net asset value plus cumulative dividend paid and proposed has increased by 1.3p to 95.0p per share, cumulative dividends representing 22.0p per share.

The net asset value currently comprises 48% in cash and gilts and as such the Company is well placed to take advantage of selective investment opportunities as they arise.

The net asset value per share remains significantly in excess of the current share price.

Outlook 

Whilst there remains uncertainty over the speed of recovery in the markets the last quarter has demonstrated that positive realisations are still possible for the right quality of investments. There is some evidence of an increasing search for capital from businesses seeking to expand which your Board believes will translate into increasing investment opportunities over both the short and medium term. This Company is well placed to continue to support these investments and take advantage of investment opportunities that may arise in the short term and is intending to ensure it has sufficient capacity to meet future investment demand. 

16 November 2009

For further information please contact:

David Hall  YFM Private Equity Tel: 0161 832 7603

Jeff Keating Singer Capital Markets Tel: 0203 205 7500

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGUGMGGUPBGWQ
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.